Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA Strategies in High-risk Non-cardiac Surgery
NCT05957822Phase 4Recruiting
- Sponsor
- Konkuk University Medical Center
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in Postoperative bleeding and hyperfibrinolysis (3 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Clot Reaction Time maximal amplitude at 24 hours. Started Feb 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Postoperative bleedinghyperfibrinolysis
Beyond the preview
Go deeper on NCT05957822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05957822.